New catalyst enables targeted antibiotic redesign to beat resistant bacteria
Antibiotics, our infantry against bacteria, are losing their ability to fight against bacterial infections due to the rise of superbugs—microbes that have developed resistance to medications that are designed to kill them. In a recent study, researchers have developed a way to chemically modify comm...
Image: Phys.org
Antibiotics, our infantry against bacteria, are losing their ability to fight against bacterial infections due to the rise of superbugs—microbes that have developed resistance to medications that are designed to kill them. In a recent study, researchers have developed a way to chemically modify common antibiotics like erythromycin A, clarithromycin, and azithromycin to help them fight drug-resistant bacteria.
Originally published at Phys.org
